Why Did Pfizer Offload This Potential Mega-Blockbuster Drug?

Submitted by admin on April 24, 2023 - 10:18am

Source:

Motley Fool

News Tags:

Headline:

snippet:

Last December, Pfizer formed a new company with Roivant Sciences to trial an experimental IBD medication.
The therapy sports a novel mechanism of action and it could be used to treat dozens of high-value indications.
While this decision may not make sense at first, Pfizer probably made the right move in this situation.

Search form